Promising therapies still need to be further evaluated in clinical trials. The first systematic review of trials of possible therapies to slow vascular calcification in chronic kidney disease (CKD) ...

A drug candidate, previously successful at treating severe fatty liver disease, reduces atherosclerosis—a primary driver of cardiovascular death worldwide—in large mammals, a study suggests. Real-time ...

Vascular calcification, low bone mass and fragility fractures are all frequent age-dependent disorders. Recent clinical and experimental data suggest that vascular calcification and bone loss could ...

Please provide your email address to receive an email when new articles are posted on . Despite presumably living a physically active lifestyle and eating a diet rich in omega-3 fatty acids, three of ...

Absence of muscle tissue in biopsy samples is common and associated with increased risk of death. In a small study, 50% of non-diabetic hemodialysis patients with elevated FGF-23 showed correlations ...

Heart disease and stroke are the world's two most deadly diseases, causing over 15 million deaths in 2016 according to the World Health Organization. A key underlying factor in both of these global ...

Please provide your email address to receive an email when new articles are posted on . In the course of 18 months, supplementation with cholecalciferol did not attenuate vascular calcification ...

Vascular stiffening and calcification, which is accelerated by aging, affects multiple organs and plays a role in dementia. There are no treatments for vascular calcification, which makes arteries ...

A collaboration between researchers at FIU’s Herbert Wertheim College of Medicine (HWCOM) and the College of Engineering & Computing (CEC) has resulted in a U.S. patent that could eventually ...

The MHRA (Medicines and Healthcare products Regulatory Agency)granted UK Marketing Authorisation for XOANACYL via the International Recognition ...